Sign In
Free Newsletter
Alba’s celiac therapy seen as promising
Alba Therapeutics Corp., of Baltimore, a developer of drugs to treat autoimmune and inflammatory diseases, said it has seen positive results from a Phase IIb clinical trial of a new drug, larazotide acetate, to treat celiac disease.
Feds say Md. owes millions for not billing drug companies for rebates
WASHINGTON — Maryland may have to refund the federal government up to $5.8 million it received as reimbursement for prescription medication through Medicaid and Medicare, after it failed to properly […]
MedImmune, Hopkins to collaborate
The Johns Hopkins University and Gaithersburg-based MedImmune LLC are beginning a five-year, $6.5 million research collaboration that will focus on identifying potential treatments for several complex diseases, officials announced Wednesday.
Baltimore biotech Gliknik, Pfizer sign accord
Gliknik Inc., of Baltimore, a biotech that develops novel molecular treatments for autoimmune/inflammatory diseases and cancer, said it has entered into an exclusive worldwide licensing agreement with drug-making giant Pfizer Inc. for its pharmaceutical candidate, GL-2045, a potential treatment for a variety of autoimmune diseases.
High court weighs drug companies’ generics policy
WASHINGTON — The Supreme Court is struggling with whether it should stop pharmaceutical corporations from paying generic drug competitors to delay releasing their cheaper versions of brand-name drugs. Justices heard […]
Wholesale prices rise 0.7 pct. on gas spike
WASHINGTON — A measure of U.S. wholesale prices rose in February by the most in five months, pushed higher by more expensive gas and pharmaceuticals. But outside those increases, inflation […]
Md. company to study cancer medicine feasibility
ROCKVILLE — A Rockville company will study the feasibility of a new cancer medicine with the large pharmaceutical company AstraZeneca. CytImmune Sciences Inc. and AstraZeneca made the announcement on Thursday. […]
Pfizer to pay $55 million in drug misbranding case
WASHINGTON — The Justice Department says Pfizer Inc. will pay $55 million to resolve allegations that Wyeth LLC promoted the drug Protonix for uses that were not approved by the […]
Prescribing poor practices?
Management at CVS allegedly has had a prescription for pharmacists at the chain’s stores: Get those automatic refills rolling or you don’t get a raise.
FDA approves Supernus’ epilepsy drug Oxtellar XR
ROCKVILLE — Supernus Pharmaceuticals Inc. said Monday that the Food and Drug Administration approved its once-per-day epilepsy drug Oxtellar XR. Its shares jumped more than 10 percent in morning trading. […]
PharmAthene shares plunge on anthrax vaccine hold
ANNAPOLIS — PharmAthene shares plummeted in morning trading Friday after the company said health regulators halted its study of an experimental anthrax vaccine. The company said the Food and Drug […]
Bristol-Myers exec charged with insider trading
NEWARK, N.J. — A Bristol-Myers Squibb executive has been charged with insider trading. The U.S. attorney’s office in Newark, N.J., says Robert Ramnarine bought and sold stock in companies that […]
